FDA Inspection 922219 — S.R. Burzynski Manufacturing Facility
The FDA completed an inspection of S.R. Burzynski Manufacturing Facility on March 18, 2015 in Stafford, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 18, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Stafford, TX (United States)